Glucagon-like peptide-1

Glucagon-like Peptide-1 (GLP-1)

Principals funcions GLP-1

Glucagon-like peptide-1 (GLP-1) is a hormone that is secreted from the intestines in response to food intake. It plays a crucial role in the regulation of blood glucose levels and has been implicated in the pathophysiology of type 2 diabetes.

Glucagon-like Peptide-1 (GLP-1) is an incretin hormone that plays a critical role in glucose metabolism, insulin secretion, and appetite regulation. Produced in the intestinal L cells and certain neurons within the brain, GLP-1 is a key player in the enteroinsular axis, mediating the increase in insulin secretion in response to nutrient intake. This article delves into the physiological functions of GLP-1, its therapeutic applications, particularly in the treatment of type 2 diabetes mellitus and obesity, and highlights recent research in the field.

Physiological Role

GLP-1 exerts multiple actions on glucose homeostasis and gastrointestinal function:

• Insulin Secretion: Enhances insulin secretion from pancreatic β-cells in a glucose-dependent manner, preventing hyperglycemic spikes post-meal.
• Gastric Emptying: Slows gastric emptying, aiding in the reduction of postprandial glucose levels.
• Appetite Regulation: Acts on the brain to promote satiety and reduce food intake, contributing to weight management.
• Glucagon Suppression: Inhibits glucagon secretion, thereby reducing hepatic glucose production.

Illustration of insulin and glucagon regulation in glucose metabolism.

Therapeutic Uses

GLP-1's role in enhancing insulin secretion and promoting satiety has led to the development of GLP-1 receptor agonists for managing type 2 diabetes and obesity:

• Type 2 Diabetes Mellitus: GLP-1 receptor agonists, such as exenatide and liraglutide, improve glycemic control by enhancing insulin secretion and suppressing glucagon release.
• Obesity: These agents reduce appetite and food intake, leading to significant weight loss in patients with obesity.

GLP-1 Receptor Agonists

GLP-1 receptor agonists mimic the action of endogenous GLP-1, offering several benefits:

• Improved glycemic control with a low risk of hypoglycemia
• Weight reduction
• Potential cardiovascular benefits

Function

GLP-1 is secreted by L cells in the intestine in response to food intake. It acts on the pancreas to stimulate insulin secretion and inhibit glucagon secretion, thereby helping to regulate blood glucose levels. GLP-1 also slows gastric emptying and promotes satiety, which can help to control body weight.

Role in disease

Impaired GLP-1 secretion and action have been implicated in the pathophysiology of type 2 diabetes. GLP-1-based therapies, such as GLP-1 receptor agonists and DPP-4 inhibitors, are currently used in the treatment of this disease.

Therapeutic use

GLP-1-based therapies are used in the treatment of type 2 diabetes. These include GLP-1 receptor agonists, which mimic the action of GLP-1, and DPP-4 inhibitors, which prevent the breakdown of GLP-1. These therapies can help to improve blood glucose control and promote weight loss.

See also

• Insulin
• Glucagon
• Type 2 diabetes
• GLP-1 receptor agonists
• DPP-4 inhibitors

References

Glucagon-like peptide-1 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia

Transform Your Life with W8MD Weight Loss Centers

W8MD offers a physician-supervised weight loss program at various locations including New York, Pennsylvania and New Jersey. Our centers provide expert medical guidance, accept most insurances, and offer telemedicine options for convenience.

Why choose W8MD?

• Comprehensive care with FDA-approved medications including:
• Weight loss injections both generic and brand names:
  • Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
• Weight loss medications including Phentermine, Qsymia, Contrave, Diethylpropion etc.
• Accept most insurances for visits or discounted self pay cost.
• Generic weight loss injections starting from just $125.00 for the starting dose
• In person weight loss NYC and telemedicine medical weight loss options in New York city available

Book Your Appointment

Start your weight loss journey today at our centers in New York, and Pennsylvania and visit W8MD.com Call (718)946-5500 for NY and 215 676 2334 for PA